FDA Center for Drug Evaluation & Research Issues Warning Letter to Empower Pharmacy
September 23, 2026
September 23, 2026
WASHINGTON, Sept. 23 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Empower Clinic Services LLC dba Empower Pharmacy from its Center for Drug Evaluation and Research:
* * *
Recipient: Arta Shaun Noorian, Founder & Chief Executive Officer, Empower Clinic Services, LLC dba Empower Pharmacy, 7601 N. Sam Houston Pkwy W., Ste. 100, Houston, TX 77064-3595, United States
(b)(4)
* * *
Recipient: Arta Shaun Noorian, Founder & Chief Executive Officer, Empower Clinic Services, LLC dba Empower Pharmacy, 7601 N. Sam Houston Pkwy W., Ste. 100, Houston, TX 77064-3595, United States
(b)(4)
